Search

everythinglearnresearchcommunity

for

Search:↓

In Brazil in 2018, the most common skin issues were acne, photoaging, and nonmelanoma skin cancer, with treatments often including topical medications and sunscreen.

The conclusion is that better understanding and more research are needed to effectively manage follicular and scarring disorders in skin of color, with an emphasis on patient education and cultural awareness.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Acne is significantly influenced by genetics, and understanding its genetic basis could lead to better, targeted treatments.

People with lichen planus are more likely to have dyslipidemia, especially higher triglyceride levels.

Most hair loss can be diagnosed with patient history and physical exam, and a few common types make up most cases.

Certain skin conditions can indicate insulin resistance and should prompt lifestyle changes and medical treatment to manage underlying health issues.

The document concludes that primary scarring alopecias cause permanent hair loss, have unpredictable outcomes, and lack definitive treatments, requiring personalized care.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Most skin changes during pregnancy are harmless and temporary, but some can risk the fetus and need careful treatment.

New gene identification techniques have improved the understanding and classification of inherited hair disorders.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Most pregnant women experience skin changes like darkening and itching, while serious skin conditions are rare but need early treatment.

Most people with Alopecia Areata don't get treatment within a year; it's costly and often comes with other health issues.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Permanent hair loss from cicatricial alopecia is treated by reducing inflammation and managing symptoms, but regrowth in scarred areas is unlikely.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Sebaceous glands play a key role in skin health, immunity, and various skin diseases.

Obesity increases the risk of skin infections, inflammatory conditions, and melanoma, but not basal cell carcinoma.

European dermatological guidelines vary in quality, with some highly rated, but improvements are needed in applicability and consistency.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

Understanding and treating hair disorders in different ethnic groups requires knowledge of specific hair care practices and hair characteristics.

Leptin affects skin and hair health and may worsen some skin conditions, but more research is needed to understand its full impact.

Sonicated platelet-rich plasma boosts hair growth by activating stem cells.

New treatments and early diagnosis methods for permanent hair loss due to scar tissue are important for managing its psychological effects.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

Skin diseases linked to insulin resistance should be managed to prevent diabetes and reduce heart disease risk.

Skin problems from transplant drugs are common and need careful management in organ transplant patients.

Teledermatology is highly accurate for diagnosing inflammatory skin conditions.

Women with lichen planopilaris often have thyroid disease, depression, anxiety, and may respond to treatment with slowed disease progression.